ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 53.1M
Number of holders: 56
Total 13F shares, excl. options: 27.3M
Shares change: +27.3M
Total reported value, excl. options: $1.03B
Value change: +$1.03B
Number of buys: 56
Price: $37.74

Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q3 2020

56 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q3 2020.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27.3M shares of 53.1M outstanding shares and own 51.28% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9.7M shares), Vivo Capital, LLC (4.22M shares), Logos Global Management LP (3.14M shares), Board of Trustees of The Leland Stanford Junior University (1.45M shares), WELLINGTON MANAGEMENT GROUP LLP (1.03M shares), Foresite Capital Management IV, LLC (974K shares), Cormorant Asset Management, LP (972K shares), BlackRock Inc. (829K shares), FMR LLC (749K shares), and VANGUARD GROUP INC (645K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.